Lorbas ,very good post , except that FDA will require quite more patients if results in TNBC very positive, IMO..

Yes , no one is sure with FDA , but with very deadly diseases , especially with no serious side effects , they doing that..

Well , here is an unusual thing , I don't believe FDA met one medicine before , during their existence , without one serious side effect , that what is confusing for them IMO...

But yes , if results very strong in TNBC , I believe it will be approved in 2020 , and with very few patients if that's what we will have..
but results must be very good..

and as always IMO only...